Clinical trial
Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic…
NCT00198302 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00198302 |
|---|---|
| Title | Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB) |
| Official title | A Phase II, Randomized, Double-blind, Multi-center Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB) |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Staphylococcus Aureus Bacteremia |
| Intervention type | Drug |
| Interventions | Aurexis® |
| Enrollment | 60 |
| Completion | Feb 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 29, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: